109 articles in this topic
A structured neuroplasticity-based program improved functional performance and emotional well-being in community-dwelling older adults with dementia.
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
A 12-month Emory trial tests partnered rhythmic dance vs. walking to protect motor-cognitive function in prodromal Alzheimer's patients.
A pilot trial tests whether group and phone-based CBT can sharpen cognition and cut chronic stress in African Americans at risk for Alzheimer's.
A VA-sponsored trial tested whether the blood pressure drug prazosin could remove toxic proteins linked to CTE and Alzheimer's in combat veterans.
Cassava Sciences' 76-week Phase 3 trial of simufilam for Alzheimer's was terminated, raising questions about the drug's future.
A completed Columbia University trial compares Family Nurture Intervention in group settings to standard programs for children ages 2–4.5.
Researchers at Duke University tested a blood-based biomarker to stratify Alzheimer's patients from healthy adults, aiming to enable earlier detection.
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
A completed RCT tests whether trained non-clinicians can guide self-help CBT for generalized anxiety disorder in seniors.
A Phase 4 real-world study comparing extended-release methylphenidate formulations for ADHD was terminated before yielding conclusions.
A completed RCT tests whether 6 months of moderate aerobic exercise protects memory and brain structure in older adults at genetic risk for Alzheimer's.
